1. Home
  2. CRNX vs HGV Comparison

CRNX vs HGV Comparison

Compare CRNX & HGV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$83.90

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Logo Hilton Grand Vacations Inc.

HGV

Hilton Grand Vacations Inc.

HOLD

Current Price

$49.16

Market Cap

4.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNX
HGV
Founded
2008
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.2B
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
CRNX
HGV
Price
$83.90
$49.16
Analyst Decision
Strong Buy
Hold
Analyst Count
8
8
Target Price
$76.75
$52.13
AVG Volume (30 Days)
6.0M
1.1M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
97.78
EPS
N/A
0.79
Revenue
$1,039,000.00
$5,047,000,000.00
Revenue This Year
$720.10
$25.30
Revenue Next Year
$184.67
$1.98
P/E Ratio
N/A
$61.15
Revenue Growth
N/A
1.33
52 Week Low
$25.83
$36.79
52 Week High
$84.00
$55.40

Technical Indicators

Market Signals
Indicator
CRNX
HGV
Relative Strength Index (RSI) 92.96 44.65
Support Level $40.74 $48.03
Resistance Level N/A $49.77
Average True Range (ATR) 0.66 1.70
MACD 1.48 -0.37
Stochastic Oscillator 99.75 24.95

Price Performance

Historical Comparison
CRNX
HGV

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

About HGV Hilton Grand Vacations Inc.

Hilton Grand Vacations Inc is a timeshare company engaged in developing, marketing, selling, managing, and operating timeshare resorts and timeshare plans under the Hilton Grand Vacations brand. The company operates in two segments: Real estate sales and financing, and Resort operations and club management. The Real estate sales and financing segment generates revenue from VOI sales and consumer financing, including interest income from loans to members. The Resort operations and club management segment generates revenue from resort management services, club membership fees, and rental of available inventory. The majority of the company's revenue is earned through the Real estate sales and financing segment.

Share on Social Networks: